Methylprednisolone in high doses gives different effects on the early and the late part of complement.
The effects of methylprednisolone (MP) on endotoxin-induced activation of complement were studied in citrated pool plasma. Complement activation was tested in two immunoassays: one evaluating C3 activation fragments (C3act) and the other the terminal complement complex (TCC). These components are indicators of initial and terminal complement activation, respectively. Plasma samples were obtained at 1, 2, 4 and 6 h of incubation. Plasma containing endotoxin (2.10(9) ng/l) without MP revealed a marked increase of both C3act and TCC after 1 h. MP in high doses (10 mg/ml) gave an additive effect on activation of the initial part of the complement cascade compared to test plasma containing only endotoxin. In contrast, endotoxin-induced activation of the terminal part of the complement cascade was inhibited by the same dose of MP. The influence of lower doses of MP (0.1 and 1 mg/ml) on endotoxin-induced activation of complement was insignificant. Interestingly, MP without endotoxin induced activation of the initial part of complement. In test plasmas containing 5 and 10 mg/ml of MP (without endotoxin) marked increases of C3act values were seen. Despite this obvious activation of the early part of complement, only insignificant changes were found in TCC values. Test plasmas containing 0.1 and 1 mg/ml of MP revealed only minor changes in both C3act and TCC. In conclusion, the present study shows that high doses of MP activate the initial part of complement and that the endotoxin-induced activation of this cascade system was facilitated by MP. The terminal part of complement was, on the other hand, inhibited by high doses of MP.
Roeise
O
O
Department of Surgery, Ullevaal Hospital, University of Oslo, Norway.
Garred
P
P
Mollnes
T E
TE
Stadaas
J O
JO
Aasen
A O
AO
D003167:Complement Activation / Q000187:drug effects*; D003176:Complement C3 / Q000502:physiology*; D003171:Complement Pathway, Classical; D004305:Dose-Response Relationship, Drug; D004731:Endotoxins / Q000494:pharmacology; D004926:Escherichia coli; D006801:Humans; D008775:Methylprednisolone / Q000494:pharmacology*; D010446:Peptide Fragments; D013997:Time Factors
D003176:Complement C3; D004731:Endotoxins; D010446:Peptide Fragments; D008775:Methylprednisolone